Catalyst Wire Dossier Catalyst Wire Dossier

L523S recombinant DNA and adenovirus vector expressing L523S protein

recombinant DNA and adenovirus expressing L523S protein · Corixa Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for L523S recombinant DNA and adenovirus vector expressing L523S protein, covering 2006-12-06 to 2006-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer [Phase 1]

See pricing